SEC Form 4 · accession 0001209191-18-048555

Bionano Genomics, Inc. · BNGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Junfeng Wang

Director · 10% Owner

Period of report

Aug 23, 2018

Accepted (ET)

Aug 27, 2018 · 6:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001411690

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Aug 23, 2018	C	199,653	—	A	199,653	I	By entities affiliated with LC Fund VI, L.P.
Common Stock^F1,F3	Aug 23, 2018	C	150,550	—	A	350,203	I	By entities affiliated with LC Fund VI, L.P.
Common Stock^F1,F4	Aug 23, 2018	C	637,984	—	A	988,187	I	By entities affiliated with LC Fund VI, L.P.
Common Stock^F5,F6	Aug 23, 2018	C	784,728	—	A	1,772,915	I	By LC Healthcare Fund I, L.P.
Common Stock^F7,F8	Aug 23, 2018	C	1,134,000	—	A	2,906,915	I	By Rosy Shine Limited

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series C Convertible Preferred Stock^F1,F2	—	Aug 23, 2018	C	8,545,184	D	—	—	Common Stock	199,653	I
Series D Convertible Preferred Stock^F1,F3	—	Aug 23, 2018	C	6,443,565	D	—	—	Common Stock	150,550	I
Series D-1 Convertible Preferred Stock^F1,F4	—	Aug 23, 2018	C	27,305,708	D	—	—	Common Stock	637,984	I

Explanation of responses

F1Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date.
F2The shares are held as follows: 191,667 shares held by LC Fund VI, L.P. ("LC Fund") and 7,986 shares held by LC Parallel Fund VI, L.P. ("Parallel Fund") LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company ("Legend Capital"). The Reporting Person is a Managing Director of Legend Capital and disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein.
F3The shares are held as follows: 143,533 shares held by LC Fund and 7,017 shares held by Parallel Fund. LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company. The Reporting Person is a Managing Director of Legend Capital. The Reporting Person disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein.
F4The shares are held as follows: 91,700 shares held by LC Fund, 540,631 shares held by Parallel Fund and 5,653 shares held by LC Healthcare Fund I, L.P. ("Healthcare Fund"). LC Fund, Parallel Fund and Healthcare Fund are controlled and managed by Legend Capital. The Reporting Person is a Managing Director of Legend Capital and disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein.
F5Represents the conversion of an outstanding convertible promissory note in the principal amount of $3,460,000, plus $144,846.03 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $6.125 per share.
F6Healthcare Fund is controlled and managed by Legend Capital, a limited liability Chinese company. The Reporting Person is a Managing Director of Legend Capital. The Reporting Person disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein.
F7Represents the conversion of an outstanding convertible promissory note in the principal amount of $5,000,000, plus $209,315.07 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $6.125 per share.
F8Rosy Shine Limited is ultimately controlled and managed by Legend Holdings, a limited liability Chinese joint stock company listed on a Stock Exchange of Hong Kong (3396), which is controlled by its board of directors. The board of directors of Legend Holdings has sole voting and investment power over the shares held by Rosy Shine Limited. None of the members of the board of directors has individual voting or investment power with respect to such shares and each disclaims beneficial ownership of such shares.